A person’s genetic code can contribute to their risk for developing non-small cell lung cancer (NSCLC), which accounts for about 85% of lung cancers. Epigenetics, the study of chemical tags that impact gene expression without altering the genetic sequence, is shown to also profoundly influence the development of cancer. In a study by Asan Medical Center researchers … Continue reading Chromatin Immunoprecipitation Study Supports HDAC Inhibitor as Possible Lung Cancer Treatment
HDAC Inhibitor Could Sharpen Memory and Treat Cancer
New research has found that a histone deacetylase (HDAC) inhibitor drug used to treat cancer could also help sharpen memory and improve one’s ability to learn a new language. It could even help rewire the brain and sustain neurons which could be of benefit to those suffering from Alzheimer’s and dementia. Researchers from Rutgers published a study … Continue reading HDAC Inhibitor Could Sharpen Memory and Treat Cancer
Dr. Eddy Bettermann MD 